GlassScriptPhysician profile
Mai Vuong
NPI 1750777520
$29,415.98
in general payments reported to CMS, 2019-2025
10 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $4,059 · 2022: $105 · 2023: $1,247 · 2024: $56.12 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $821 · Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $820.67 |
| Food and Beverage | $800.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19,227.59 | 2019-2025 | General - Dbs |
| Medtronic USA, INC. | $8,333.33 | 2020 | |
| Medtronic, INC. | $952.27 | 2023 | Percept PC Brainsense |
| Abbvie INC. | $293.96 | 2022-2025 | Duopa |
| Acadia Pharmaceuticals INC | $214.82 | 2023 | Nuplazid |
| Teva Pharmaceuticals USA, INC. | $133.15 | 2019 | |
| Kyowa Kirin, INC. | $124.77 | 2020 | |
| Acorda Therapeutics, INC | $58.80 | 2021 | |
| Ucb, INC. | $58.64 | 2023 | |
| Medtronic Vascular, INC. | $18.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Vuong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.